Predictors of early mortality in veteran patients with pancreatic cancer

American Journal of Surgery

Volumn 194, Issue 3, 2007, Pages 362-366

  Siddiqui, Ali ^a   Heinzerling, John ^a   Livingston, Edward H ^a   Huerta, Sergio ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Multivariate analysis; Pancreatic neoplasms; Prognosis; Univariate analysis

Indexed keywords

ALKALINE PHOSPHATASE; CA 19-9 ANTIGEN; SERUM ALBUMIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER SURVIVAL; HUMAN; LAPAROTOMY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PANCREAS CANCER; PANCREATICODUODENECTOMY; PREDICTION; PRIORITY JOURNAL; VETERAN;

HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; VETERANS;

EID: 34547681625     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.02.007     Document Type: Article

References (21)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Beger H.G., Rau B., Gansauge F., et al. Treatment of pancreatic cancer: challenge of the facts. World J Surg 27 (2003) 1075-1084
3. Bottger T., Zech J., Weber W., et al. [Prognostically relevant factors in ductal pancreatic cancer]. Chirurg 60 (1989) 521-528
4. Fujino Y., Suzuki Y., Ajiki T., et al. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline. Hepatogastroenterology 50 (2003) 250-253
5. Terwee C.B., Nieveen Van Dijkum E.J., Gouma D.J., et al. Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study. Triple-P Study Group. Eur J Surg 166 (2000) 706-712
6. Krishnan S., Rana V., Janjan N.A., et al. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107 (2006) 2589-2596
7. Cubiella J., Castells A., Fondevila C., et al. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials. Am J Gastroenterol 94 (1999) 1271-1278
8. Lillemoe K.D., Cameron J.L., Hardacre J.M., et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer?. A prospective randomized trial. Ann Surg 230 (1999) 322-328
9. Prat F., Chapat O., Ducot B., et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 42 (1998) 76-80
10. Kau S.Y., Shyr Y.M., Su C.H., et al. Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers. J Am Coll Surg 188 (1999) 415-420
11. Ueno H., Okada S., Okusaka T., et al. Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 59 (2000) 296-301
12. Kilic M., Gocmen E., Tez M., et al. Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer. Can J Surg 49 (2006) 241-244
13. Engelken F.J., Bettschart V., Rahman M.Q., et al. Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol 29 (2003) 368-373
14. Gibbs J., Cull W., Henderson W., et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 134 (1999) 36-42
15. Sirott M.N., Bajorin D.F., Wong G.Y., et al. Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 72 (1993) 3091-3098
16. McMillan D.C., Watson W.S., O'Gorman P., et al. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39 (2001) 210-213
17. Schmid I., Schmitt M., Streiter M., et al. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia. Eur J Med Res 10 (2005) 457-461
18. Vigano A., Bruera E., Jhangri G.S., et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 160 (2000) 861-868
19. Nakamura K., Takahashi T., Tsuyuoka R., et al. Identification of colony-stimulating factor activity in patients with malignant tumors associated with excessive leukocytosis. Jpn J Clin Oncol 21 (1991) 395-399
20. Ohwada S., Miyamoto Y., Fujii T., et al. [Colony stimulating factor producing carcinoma of the pancreas-a case report]. Gan No Rinsho 35 (1989) 523-527
21. Falconer J.S., Fearon K.C., Ross J.A., et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 75 (1995) 2077-2082